“Time Is Muscle” Only in Experienced Hands and High-Volume Centers

Abstract

Get full access to this article

View all access options for this article.

References

Eagle KA , Goodman SG , Avezum A. , et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002 ;359:373-377.

Simes RJ , Topol EJ , Holmes DR Jr , et al, for the GUSTO-I Investigators. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion. Circulation 1995;91:1923-1928.

Chesebro JH , Knatterud G. , Roberts R. , et al. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 1987;76:142-154.

Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients . Lancet 1994;343:311-322.

Goswami NJ , Moody JM Jr , Bailey SR Percutaneous mechanical reperfusion during acute myocardial infarction . J Intensive Care Med 2002;17:162-173.

Hartzler GO , Rutherford BD , McConahay DR , et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983;106:965-973.

O'Neil W. , Timmis GC , Bourdillon PD , et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplast for acute myocardial infarction. N Engl J med 1986;812-818.

Brodie BR , Stuckey TD , Wall TC , et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998 ;32:1312-1319.

Stone GW , Cox D. , Garcia E. , et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the Primary Angioplasty in Myocardial Infarction trials. Circulation 2001;104:636-641.

10.

Gibson CM , Cannon CP , Murphy SA , et al; for the TIMI (Thrombolysis In Myocardial Infarction) Study Group. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circ 2000; 101(2):125-130.

11.

Ryan TJ , Antman EM , Brooks NH , et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) . Circulation 1999;100:1016-1030.